O'Neill LAJ - Search Results

1

Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma.

Pinkerton JW, Kim RY, Brown AC, Rae BE, Donovan C, Mayall JR, Carroll OR, Khadem Ali M, Scott HA, Berthon BS, Baines KJ, Starkey MR, Kermani NZ, Guo YK, Robertson AAB, O'Neill LAJ, Adcock IM, Cooper MA, Gibson PG, Wood LG, Hansbro PM, Horvat JC. Pinkerton JW, et al. J Allergy Clin Immunol. 2022 Apr;149(4):1270-1280. doi: 10.1016/j.jaci.2021.10.003. Epub 2021 Oct 19. J Allergy Clin Immunol. 2022. PMID: 34678326

2

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.

Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Pétrilli V, Tschopp J, O'Neill LA, Lavelle EC. Sharp FA, et al. Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):870-5. doi: 10.1073/pnas.0804897106. Epub 2009 Jan 12. Proc Natl Acad Sci U S A. 2009. PMID: 19139407 Free PMC article.

3

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA. Masters SL, et al. Nat Immunol. 2010 Oct;11(10):897-904. doi: 10.1038/ni.1935. Epub 2010 Sep 12. Nat Immunol. 2010. PMID: 20835230 Free PMC article.

4

The inflammasome in atherosclerosis and type 2 diabetes.

Masters SL, Latz E, O'Neill LA. Masters SL, et al. Sci Transl Med. 2011 May 4;3(81):81ps17. doi: 10.1126/scitranslmed.3001902. Sci Transl Med. 2011. PMID: 21543720

5

The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes.

Coll RC, Robertson A, Butler M, Cooper M, O'Neill LA. Coll RC, et al. PLoS One. 2011;6(12):e29539. doi: 10.1371/journal.pone.0029539. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216309 Free PMC article.

6

Biochemical regulation of the inflammasome.

Dowling JK, O'Neill LA. Dowling JK, et al. Crit Rev Biochem Mol Biol. 2012 Sep;47(5):424-43. doi: 10.3109/10409238.2012.694844. Epub 2012 Jun 11. Crit Rev Biochem Mol Biol. 2012. PMID: 22681257 Review.

7

Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production.

Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O'Neill LA, Masters SL. Haneklaus M, et al. J Immunol. 2012 Oct 15;189(8):3795-9. doi: 10.4049/jimmunol.1200312. Epub 2012 Sep 14. J Immunol. 2012. PMID: 22984081

8

Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments.

Haneklaus M, O'Neill LA, Coll RC. Haneklaus M, et al. Curr Opin Immunol. 2013 Feb;25(1):40-5. doi: 10.1016/j.coi.2012.12.004. Epub 2013 Jan 7. Curr Opin Immunol. 2013. PMID: 23305783 Review.

9

NLRP3 and IL-1β in macrophages as critical regulators of metabolic diseases.

McGettrick AF, O'Neill LA. McGettrick AF, et al. Diabetes Obes Metab. 2013 Sep;15 Suppl 3:19-25. doi: 10.1111/dom.12169. Diabetes Obes Metab. 2013. PMID: 24003917 Review.

10

Cardiolipin and the Nlrp3 inflammasome.

O'Neill LA. O'Neill LA. Cell Metab. 2013 Nov 5;18(5):610-2. doi: 10.1016/j.cmet.2013.10.013. Cell Metab. 2013. PMID: 24206659 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

436 results

Search Page